The GLP is committed to full transparency. Download and review our 2019 Annual Report

Can we slow the effects of aging?

| December 3, 2013

A few months ago, Google announced that it would be tackling the challenge of aging.

Though their announcement was very vague, it was assumed that their new company, Calico, would utilize Big Data to treat chronic diseases that affect the elderly, such as cancer, heart disease and Alzheimer’s. But many thought that the company would do more than just try to treat the aging process, but rather attempt to slow the process altogether.

“For some scientists, recent anti-aging research — on gene therapy, body-part replacement by regeneration and nanotechnology for repairing aging cells — has breathed new life into this dream,” writes The New York Times‘ Daniel Callahan. “They also point to the many life-extending medical advances of the past century as precedents, with no end in sight, and note that average life expectancy in the United States has long been rising, from 47.3 in 1900 to 78.7 in 2010.”

Read the full, original story here: On Dying After Your Time

Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend